Paper2835685
Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings.
Schnell N and 6 others. Nature, 1988. Cited by 401 papers, by iCite.
Cite this record
ConductScience Library. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Papers, record 2835685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2835685
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Genes | Major topic |
| Genes, Bacterial | Major topic |
| Peptides | Major topic |
| Amino Acid Sequence | |
| Bacteriocins | |
| Base Sequence | |
| DNA Restriction Enzymes | |
| Molecular Sequence Data | |
| Peptides, Cyclic | |
| Protein Conformation | |
| Staphylococcus epidermidis |
Source PubMed
Cited by199
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 401 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42454909 | mSphere Legacy: Fritz about Fritz. | mSphere | 2026 | https://conductscience.org/library/papers/42454909 | PubMed |
| 42415656 | Structure and Activity of Class II Lanthipeptides From a Thermophilic Bacterium. | Chembiochem | 2026 | https://conductscience.org/library/papers/42415656 | PubMed |
| 42348069 | The Bacterial Landscape of Facial Skin: From Homeostasis to Skin Conditions. | Dermatol Ther (Heidelb) | 2026 | https://conductscience.org/library/papers/42348069 | PubMed |
| 42129607 | PEP-EDIT: a web server for the 3D generation and interactive editing of complex peptides. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/42129607 | PubMed |
| 41959303 | Structure and Activity of Class II Lanthipeptides from a Thermophilic Bacterium. | bioRxiv | 2026 | https://conductscience.org/library/papers/41959303 | PubMed |
| 41911463 | Co-opting the bacterial lipoprotein pathway for the biosynthesis of lipidated macrocyclic peptides. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41911463 | PubMed |
| 41801023 | Structural and functional insights into lactobacin A: a novel non-pediocin-like bacteriocin from a Liquorilactobacillus strain related to L. mali. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/41801023 | PubMed |
| 41612008 | S9 protease WprP2 catalyzes uniform cleavage on the precursor peptide in RiPP biosynthesis. | Commun Chem | 2026 | https://conductscience.org/library/papers/41612008 | PubMed |
| 41279403 | Co-opting the bacterial lipoprotein pathway in the biosynthesis of a lipidated macrocyclic peptide. | bioRxiv | 2025 | https://conductscience.org/library/papers/41279403 | PubMed |
| 40853140 | Staphylococcus epidermidis-key to understanding biofilms, commensalism, and more. | J Bacteriol | 2025 | https://conductscience.org/library/papers/40853140 | PubMed |
| 40721579 | Combatting virulent gut bacteria by inhibiting the biosynthesis of a two-component lanthipeptide toxin. | Nat Commun | 2025 | https://conductscience.org/library/papers/40721579 | PubMed |
| 40485827 | Transcriptomic insights into the interplay between polyketide biosynthesis and other secondary metabolite biosynthetic clusters and biological pathways in entomopathogen Beauveria bassiana. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40485827 | PubMed |
| 40422799 | Novel Anti-MRSA Peptide from Mangrove-Derived Virgibacillus chiguensis FN33 Supported by Genomics and Molecular Dynamics. | Mar Drugs | 2025 | https://conductscience.org/library/papers/40422799 | PubMed |
| 39895627 | Skin microbiome and dermatologic disorders. | J Clin Invest | 2025 | https://conductscience.org/library/papers/39895627 | PubMed |
| 39774303 | De novo design of ribosomally synthesized and post-translationally modified peptides. | Nat Chem | 2025 | https://conductscience.org/library/papers/39774303 | PubMed |
| 39539524 | Reconstruction of the Reaction of Andalusicin Lantibiotic Modification by Lanthionine Synthetase AncKC in a Heterologous Escherichia coli System. | Acta Naturae | 2024 | https://conductscience.org/library/papers/39539524 | PubMed |
| 39185197 | Bibacillin 1: A two-component lantibiotic from Bacillus thuringiensis. | bioRxiv | 2024 | https://conductscience.org/library/papers/39185197 | PubMed |
| 39021782 | Insights into the production and evolution of lantibiotics from a computational analysis of peptides associated with the lanthipeptide cyclase domain. | R Soc Open Sci | 2024 | https://conductscience.org/library/papers/39021782 | PubMed |
| 38832774 | The two-component regulatory systems GraRS and SrrAB mediate Staphylococcus aureus susceptibility to Pep5 produced by clinical isolate of Staphylococcus epidermidis. | Appl Environ Microbiol | 2024 | https://conductscience.org/library/papers/38832774 | PubMed |
| 38556942 | What is the role of microbial biotechnology and genetic engineering in medicine? | Microbiologyopen | 2024 | https://conductscience.org/library/papers/38556942 | PubMed |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | X07840 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2835685
GET https://conductscience.org/api/papers/v1/2835685/cited_by?page=2